H4CBD ban in France: a narcotic since 3 June 2024

The Agence nationale de sécurité du médicament (ANSM) keeps France's list of narcotics. On 22 May 2024 it added new cannabinoids to that list, with the ban taking effect on 3 June 2024. The decision of 22 May 2024 names two CBD derivatives, H2CBD (dihydrocannabidiol) and H4CBD (tetrahydrocannabidiol), plus eight synthetic cannabinoids.

It also covers, more broadly, "any substance derived from the benzo[c]chromene nucleus". That chemical core is the one found in THC. The wording therefore catches HHC, HHCO, HHCP, HHCPO and THCP in one go, without naming them one by one. Cannabinol (CBN) is excluded from the start.

An amending decision of 3 June 2024, published on 4 June, spelled out the exclusions. CBN and its acid form CBNA stay off the list, as do THCV and THCVA up to 0.3%, and THCA when it comes from hemp that complies with the order of 30 December 2021. THCA in a compliant flower is therefore not banned, whatever you may read. Our article on THCA covers this point.

H4CBD is a semi-synthetic cannabinoid. You start with CBD extracted from hemp, then react it with hydrogen in the presence of a catalyst. This is hydrogenation, the same process used to harden vegetable oils. The molecule gains four hydrogen atoms, hence the "H4" in its name. H2CBD gains two.

The chemistry has been known for a long time. In 2006, an Israeli team hydrogenated CBD and obtained several forms of these derivatives, published in the Journal of Medicinal Chemistry. The authors said they were surprised: the derivatives bound well to the CB1 receptor, the target through which THC produces its effects, whereas CBD binds to it only weakly. Their activity also differed from that of the starting CBD.

On the European market, the molecule is recent. The United Nations Office on Drugs and Crime (UNODC) notes that H4-CBD was reported for the first time in 2023, on the heels of HHC. These substances, the UNODC adds, can be manufactured from hemp CBD.

One naming trap is worth flagging. H4CBD is called tetrahydrocannabidiol. THC is called tetrahydrocannabinol. The two names differ by a few letters and describe two different molecules, both of them controlled.

The ANSM relies on reports from France's addiction monitoring centres, which track the effects of psychoactive substances. For these new cannabinoids, it lists serious effects: vomiting, loss of consciousness, coma, seizures, paranoia, anxiety, high blood pressure and a racing heart. Users described them as more intense than cannabis, with a risk of dependence.

The ban did not empty the market. On 19 June 2025, the ANSM and Anses warned of several hundred poisonings recorded since early 2024 among people using products sold as CBD. Tests found HHC, HHC-O, H4-CBD, H2-CBD or MDMB-PINACA, a synthetic cannabinoid, or THC above the threshold. In most cases the label did not match the contents.

An addiction monitoring study carried out with the toxicology laboratory of Lille University Hospital confirms this. Out of 223 "CBD" products bought in 2022 and 2023, 12 contained an undeclared semi-synthetic cannabinoid, or 5.4%. H4-CBD was among the molecules found, along with HHC. Our guide to synthetic cannabinoids in CBD covers these risks.

Since 3 June 2024, H4CBD falls under French narcotics law, with no tolerance threshold. The 0.30% limit applies only to Δ⁹-THC in hemp; it makes no amount of H4CBD legal. Our article on the legal THC level explains that threshold.

The fixed fine for drug use has been €500 since 20 August 2026. For a retailer, there is nothing to debate: a single H4CBD product on the shelf amounts to possessing and offering a narcotic.

The table below places H4CBD among related molecules, as of 23 September 2026.

Our articles on HHC and THCP trace those two other bans.

The first clue is the label. A product that lists "H4CBD", "H4-CBD", "tetrahydrocannabidiol", "hydrogenated CBD" or "CBD hydrogéné" is illegal in France. Be wary, too, of a product sold as "stronger than CBD" or with a "THC-like effect": compliant CBD does not get you high, and that promise often points to an additive.

The second clue is the lab report. The Lille study shows that a laboratory can test for H4-CBD, HHC or Δ⁸-THC using liquid chromatography coupled with mass spectrometry. It still has to look for them. On a certificate, check that these molecules appear in the list of compounds tested, with a "not detected" result and a detection limit. A certificate that lists only CBD and THC says nothing about derivatives.

Our guide to reading a certificate of analysis goes through each line, and the laboratory page describes the measurement methods. If you get an unexpected effect after a product sold as CBD, stop using it and call a poison control centre; keep the product so it can be tested.